Image: Select Access is a targeted sales force solution leveraging an existing infrastructure for Rx, seasonal, otc and pulse pharmaceutical brands
 
Button: Services for Rx Brands Button: Services for Seasonal/Pulse Brands Button: Services for Specialty Brands Button: Services for Ethical Over-the-Counter (OTC) Brands
1
About Us Markets Served Press & Media Target Coverage Contact Us PDI INC. Link to Home
 

News Releases

PDI’s Select Access Announces Extension of Sales Service Agreement with Top10- Pharma Company through April 2009

Saddle River, NJ – (January 10, 2008) PDI, Inc. (NASDAQ: PDII), a provider of commercialization services to the biopharmaceutical industry, today announced that it has extended its sales services agreement with a top-10 pharmaceutical company through April 2009 to promote its leading anti-viral medication on a seasonal basis. The company will continue to utilize PDI’s Select Access team for an additional two seasons to reach primary care physicians and will be exclusive to pediatric targets. This initiative is expected to generate approximately $10.5M during the 2007-2008 promotional seasonal.

Michael Marquard, PDI’s CEO commented, “The utilization of PDI for a third consecutive season validates PDI’s continual emphasis on flawless execution. We are very pleased to have extended our agreement with such an important customer and are excited about the opportunity to build upon our relationship.”

Select Access is a unique selling model in which multiple, non-competitive clients can utilize a highly proven, fully operational sales force with established physician relationships in high potential zip codes nationwide. Since the sales team, and its cost, are leveraged across multiple clients, Select Access is effective for the promotion of a broad range of pharmaceutical products including established, seasonal, specialty prescription and over-the-counter products.

Nancy Connelly, Senior Vice President of Sales Services commented, "We believe performance was the primary driver of this contract extension since sales attributable to our exclusive targets have increased substantially for two consecutive seasons. Select Access has continually proven to be an impactful and highly flexible asset that helps our clients maximize their return on investment."

About Select Access

Select Access, a targeted sales solution for a diverse group of pharmaceutical products, leverages an existing infrastructure to maximize brand profitability. Rapid deployment and national coverage by approximately 350 experienced sales representatives in high prescribing territories increases speed to impact. Select Access™ is the only alternative sales force model that gives clients complete target audience control and flexibility and where the majority of sales calls are single detail.

Select Access' unmatched value is perfectly aligned to increase incremental revenue for seasonal, established, and OTC brands, and for specialty brands that could gain an additional revenue stream from a primary care presence.

About PDI

PDI provides commercialization services for established and emerging biopharmaceutical companies. The Company is dedicated to maximizing the return on investment for its clients by providing strategic flexibility; sales, marketing and commercialization expertise.

PDI operates in two areas, Sales Services and Marketing Services. Our Sales Services include Performance Sales Teams™, which are dedicated teams for specific customers; Select Access™, our targeted sales solution that leverages an existing infrastructure; and PDI ON DEMAND, innovative sales services that provide rapid, customized sales force solutions tailored to meet local, regional and seasonal needs. Our Marketing Services include marketing research and consulting services through TVG in Dresher, PA, and medical communications services through Pharmakon in Schaumburg, IL. In addition, PDI is a high-quality provider of continuing medical education through Vital Issues in Medicine (VIM®), located in Dresher, PA. PDI's experience extends across multiple therapeutic categories and includes office- and hospital-based initiatives.

PDI's commitment is to deliver innovative solutions, unparalleled execution and superior results for its customers. Recognized as an industry pioneer, PDI remains committed to continuous innovation and to retaining the industry's highest-quality employees. For more information, please visit the Company's website at www.pdi-inc.com.

CONTACT: PDI, Inc.
Jeffrey E. Smith, Chief Financial Officer
201-258-8451
jesmith@pdi-inc.com
www.pdi-inc.com
or
Investor Contacts:
Lippert/Heilshorn & Associates, Inc.
Kim Sutton Golodetz, 212-838-3777
kgolodetz@lhai.com
Bruce Voss, 310-691-7100
bvoss@lhai.com

SOURCE: PDI, Inc.


Copyright © Select Access, a division of PDI, Inc. • Information Privacy Policy

About Select Access | Markets Served | Press & Media | Target Coverage Analysis | Contact Us | PDI, Inc.

Site Tools  

3
2
4

Information Resources       

Multimedia

Podcast Feeds

Video Clips

ROI & Results

View Case Studies

Select Access Overview

Conferences & Events

Scheduled Appearances

Link to Select Access Home page